Huapont Life Sciences Co Ltd
SZSE:002004

Watchlist Manager
Huapont Life Sciences Co Ltd Logo
Huapont Life Sciences Co Ltd
SZSE:002004
Watchlist
Price: 5.26 CNY 0.57% Market Closed
Market Cap: ¥10.4B

Balance Sheet

Balance Sheet Decomposition
Huapont Life Sciences Co Ltd

Balance Sheet
Huapont Life Sciences Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
23
37
33
237
126
98
160
184
165
147
657
765
1 168
2 771
5 965
6 033
7 716
4 350
1 874
2 216
2 503
4 187
2 828
3 290
Cash
0
0
0
0
0
0
0
0
0
0
1
1
1
0
1
3
5
2
1
1
2 503
4 187
2 828
3 290
Cash Equivalents
23
37
33
237
126
98
160
184
165
147
656
764
1 167
2 771
5 964
6 030
7 711
4 348
1 873
2 215
0
0
0
0
Short-Term Investments
0
0
0
4
7
8
0
0
0
0
0
88
173
3
107
1 563
1 211
0
1 323
1 698
1 636
706
1 827
2 210
Total Receivables
18
23
32
43
46
63
134
95
87
119
694
1 197
1 407
1 270
2 150
2 953
3 577
3 079
2 959
2 833
3 621
2 877
2 972
3 133
Accounts Receivables
14
20
31
29
33
53
56
66
61
70
533
1 005
1 131
982
1 572
2 284
2 671
2 505
2 070
1 925
2 381
1 927
1 512
2 185
Other Receivables
4
3
1
14
13
10
78
29
26
49
161
192
276
288
578
669
906
574
889
908
1 241
950
1 460
949
Inventory
33
29
17
20
20
84
94
105
116
145
400
551
676
942
1 212
1 503
1 935
1 950
2 092
1 951
2 402
2 536
2 675
2 253
Other Current Assets
12
50
2
7
8
6
92
30
48
17
123
134
78
463
139
477
337
1 624
1 811
2 104
2 152
1 249
1 085
390
Total Current Assets
86
140
85
310
207
259
480
415
416
428
1 874
2 735
3 500
5 448
9 574
12 529
14 775
11 003
10 059
10 803
12 314
11 554
11 387
11 277
PP&E Net
41
48
52
118
145
324
402
422
402
418
847
1 326
1 674
2 849
3 326
3 213
5 739
6 478
7 247
7 674
8 048
8 946
10 246
10 027
PP&E Gross
41
48
52
118
145
324
402
422
402
418
847
1 326
1 674
0
3 326
3 213
5 739
6 478
7 247
7 674
8 048
0
10 246
10 027
Accumulated Depreciation
11
14
18
35
45
139
165
176
208
231
386
508
646
0
1 448
1 727
2 855
3 293
3 738
4 100
4 627
0
5 696
6 247
Intangible Assets
0
2
71
48
51
77
89
64
62
99
236
395
416
569
1 183
1 289
1 511
1 493
1 461
1 644
1 731
1 759
1 652
1 619
Goodwill
0
0
0
0
0
29
31
23
22
22
869
950
1 072
1 678
2 985
3 124
3 606
3 531
3 465
3 465
3 440
2 948
2 740
2 032
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
31
33
0
0
0
0
0
180
0
15
25
Long-Term Investments
5
17
16
5
74
79
75
210
229
377
333
481
1 013
2 739
2 202
3 528
2 795
2 994
3 154
3 213
3 303
3 690
3 627
3 312
Other Long-Term Assets
1
0
0
0
1
12
11
13
11
15
30
35
66
254
407
545
1 044
1 146
1 250
1 426
1 028
1 132
1 059
1 159
Other Assets
0
0
0
0
0
29
31
23
22
22
869
950
1 072
1 678
2 985
3 124
3 606
3 531
3 465
3 465
3 440
2 948
2 740
2 032
Total Assets
133
N/A
207
+56%
225
+9%
481
+114%
478
-1%
781
+63%
1 089
+39%
1 147
+5%
1 143
0%
1 358
+19%
4 189
+208%
5 922
+41%
7 741
+31%
13 568
+75%
19 710
+45%
24 228
+23%
29 471
+22%
26 644
-10%
26 636
0%
28 226
+6%
30 044
+6%
30 029
0%
30 727
+2%
29 450
-4%
Liabilities
Accounts Payable
6
5
11
18
7
30
34
47
41
26
405
562
495
528
484
752
925
763
729
1 010
2 439
1 202
2 703
2 266
Accrued Liabilities
3
4
5
6
8
26
8
8
11
10
19
2
91
88
153
197
324
375
336
355
409
423
424
432
Short-Term Debt
13
63
35
22
0
95
177
152
84
165
893
1 775
2 003
3 501
3 217
6 405
7 817
6 919
6 876
8 158
6 677
5 750
5 962
4 796
Current Portion of Long-Term Debt
0
5
0
0
0
31
22
30
0
0
0
15
15
174
239
1 145
514
2 229
1 531
586
1 201
1 688
1 028
2 332
Other Current Liabilities
17
27
9
23
17
48
73
71
81
99
170
391
777
370
1 466
2 121
565
457
1 489
1 612
663
2 050
516
590
Total Current Liabilities
40
104
61
70
32
229
314
308
216
300
1 487
2 746
3 382
4 661
5 558
10 621
10 145
10 743
10 960
11 721
11 389
11 112
10 634
10 415
Long-Term Debt
5
0
10
0
0
5
32
2
2
1
46
22
124
3 026
3 558
2 695
5 499
2 752
2 014
1 839
2 273
1 784
2 932
2 997
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
19
52
51
63
98
99
106
105
116
108
103
110
112
105
Minority Interest
0
2
1
23
10
76
61
61
59
60
193
274
215
156
887
1 059
3 941
3 684
3 903
4 507
5 714
6 359
6 480
6 136
Other Liabilities
1
1
9
9
5
8
12
16
28
21
52
145
155
152
85
108
206
294
303
422
455
473
465
461
Total Liabilities
46
N/A
106
+130%
81
-24%
103
+27%
47
-54%
318
+577%
419
+32%
386
-8%
305
-21%
383
+26%
1 796
+369%
3 240
+80%
3 927
+21%
8 058
+105%
10 187
+26%
14 583
+43%
19 897
+36%
17 579
-12%
17 296
-2%
18 597
+8%
19 935
+7%
19 837
0%
20 622
+4%
20 113
-2%
Equity
Common Stock
66
66
66
132
132
132
132
132
132
132
167
502
581
676
2 035
2 035
2 035
2 035
1 980
1 980
1 980
1 980
1 980
1 980
Retained Earnings
21
34
74
104
156
187
394
490
574
706
1 012
1 260
1 392
1 619
2 026
2 182
2 392
2 487
2 664
2 876
3 110
3 070
2 936
2 201
Additional Paid In Capital
0
0
4
143
143
144
144
139
132
137
1 214
920
1 842
3 299
5 547
5 473
5 180
4 843
4 680
4 885
5 214
5 249
5 290
5 304
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125
0
113
144
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
66
38
0
0
270
0
0
0
0
0
30
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
18
47
45
33
29
17
111
69
108
11
25
Total Equity
87
N/A
101
+16%
144
+43%
378
+163%
431
+14%
463
+7%
670
+45%
761
+14%
838
+10%
975
+16%
2 393
+145%
2 683
+12%
3 814
+42%
5 510
+44%
9 523
+73%
9 645
+1%
9 574
-1%
9 066
-5%
9 341
+3%
9 629
+3%
10 109
+5%
10 192
+1%
10 105
-1%
9 337
-8%
Total Liabilities & Equity
133
N/A
207
+56%
225
+9%
481
+114%
478
-1%
781
+63%
1 089
+39%
1 147
+5%
1 143
0%
1 358
+19%
4 189
+208%
5 922
+41%
7 741
+31%
13 568
+75%
19 710
+45%
24 228
+23%
29 471
+22%
26 644
-10%
26 636
0%
28 226
+6%
30 044
+6%
30 029
0%
30 727
+2%
29 450
-4%
Shares Outstanding
Common Shares Outstanding
743
743
743
990
990
990
990
990
990
990
1 256
1 256
1 452
1 689
2 035
2 035
2 035
1 981
1 980
1 980
1 980
1 980
1 980
1 980
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett